Comparative assessment of patients' admission to urology departments during and before the COVID-19 pandemic: a retrospective cohort study

Abstract

Aim: To determine the diseases that presented to the urology department during the COVID-19 pandemic and for hospital-based comparison with the diseases that presented in the same period of the previous year. Material and Method: In this retrospective follow-up study, patients who were admitted to the tertiary university hospital and secondary state hospital urology departments between April-July 2019 and April-July 2020 were included in the study. We searched the health administrative data using the International Classification of Diseases-10 codes. The number and variety of patients who were admitted to the urology departments in the same months of 2019 and 2020 were compared. Results: In both hospitals, the total number of admissions decreased during the pandemic in 2020 compared to the pre-pandemic year. Also, elective admissions decreased in 2020 compared to the pre-pandemic year (p <0.001). In a significant part of the urological disease group, the decrease in the number of admissions was found to be higher for the second-level center than for the tertiary center hospital. Conclusion: We documented that uro-oncology outpatient admissions could continue during the COVID-19 pandemic in a university hospital- not primarily served as a pandemic hospital- by taking preventive measures and prioritizing healthcare personnel and patient safety.

Keywords

• COVID-19
• urologic diseases
• pandemics

References

1. Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
2. Stensland KD, Morgan TM, Moinzadeh A, et al. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol 2020; 77: 663–6.
3. Ribal MJ, Cornford P, Briganti A, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol 2020;78: 21–8.
4. Coronavirus Disease (COVID-19) Situation Reports [Internet].[cited 2021 Mar 28]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
5. Wong J, Goh QY, Tan Z, et al. Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anaesth 2020; 67: 732–45.
6. Keles E, Akis S, Kemal Ozturk U, Eser Ozyurek S, Api M. Gynecological surgeries during the COVID-19 pandemic in Turkey. Int J Gynaecol Obstet 2020; 151: 141-4.
7. Tefik T, Guven S, Villa L, et al. Urolithiasis Practice Patterns Following the COVID-19 Pandemic: Overview from the EULIS Collaborative Research Working Group. Eur Urol 2020; 78: e21–4.
8. Proietti S, Gaboardi F, Giusti G. Endourological stone management in the era of the COVID-19. Eur Urol 2020; 78: 131–3.

9. Puliatti S, Eissa A, Eissa R, et al. COVID-19 and urology: a comprehensive review of the literature. BJU Int 2020; 125: E7–E14.
10. Flammia S, Salciccia S, Tufano A, Busetto GM, Ricciuti GP, Sciarra A. How urinary stone emergencies changed in the time of COVID-19? Urolithiasis 2020; 48: 467-9.
11. Al-Shamsi HO, Alhazzani W, Alhuraiji A, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist 2020; 25: e936-45.
12. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335-7.
13. Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020; 21: e181.
14. Zequi SC, Abreu D. Consideration in the management of renal cell carcinoma during the COVID-19 pandemic. Int Braz J Urol 2020; 46: 69–78.
15. Gravas S, Fournier G, Oya M, et al. Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines. Eur Urol Focus 2020; 6: 1104–10.
16. Professionals S-O. EAU Guidelines: Non-muscle-invasive Bladder Cancer [Internet]. Uroweb. [cited 2020 Dec 5]. Available from: https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/
17. Esperto F, Pang KH, Albisinni S, Papalia R, Scarpa RM. Bladder cancer at the time of COVID-19 outbreak. Int Braz J Urol 2020; 46: 62–8.
18. Darlington CD, Mammen RJ, Mammen KJ. COVID-19 and its impact on genitourinary malignancies. Indian J Urol 2020; 36: 163–170.
19. Carneiro A, Wroclawski ML, Nahar B, et al. Impact of the COVID-19 pandemic on the urologist’s clinical practice in Brazil: a management guideline proposal for low- and middle-income countries during the crisis period. Int Braz J Urol 2020; 46: 501–10.
20. Nappi L, Ottaviano M, Rescigno P, et al. Italian Germ Cell Cancer Group (IGG) ERN-EURACAN Domain G3 Genitourinary Medical Oncologists of Canada (GUMOC) Management of germ cell tumors during the outbreak of the novel coronavirus disease-19 pandemic: a survey of international expertise centers. Oncologist 2020; 25: 1509–15.
21. Bozkurt O, Sen V, Irer B, et al. Nation-wide analysis of the impact of the Covid-19 pandemic on daily urology practice in Turkey. Int J Clin Pract 2021; 75: e13735.
22. Icarra V, Novara G, Abrate A, et al. Urology practice during the COVID-19 pandemic. Minerva Urol Nefrol 2020; 72: 369-75.
23. Karagöz MA, Gül A, Borg C, et al. Influence of COVID-19 pandemic on sexuality: a cross-sectional study among couples in Turkey. Int J Impot Res 2020; 33: 815-23.